ELV

Elevance Health operates as a health benefits company, offering a variety of health plans and services across different segments like Health Benefits, CarelonRx, and Carelon Services. The company caters to a diverse clientele, including individuals, employer groups, and government-sponsored programs. Elevance Health possesses a strong competitive position due to its established brand, extensive network, and diversified service offerings. They are focused on expanding their Carelon services to drive future growth.

The current stock price of Elevance Health is below the average target price, suggesting it may be undervalued by the market. The P/E ratio and forward P/E ratio indicate a reasonable valuation compared to its earnings. Considering its growth prospects and financial stability, Elevance Health presents an attractive valuation for long-term investors. However, the PEG ratio is null, which makes it difficult to assess the valuation relative to growth.